(±)-1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisochinolin Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R26/28:Sehr giftig beim Einatmen und Verschlucken.
R40:Verdacht auf krebserzeugende Wirkung.
S-S?tze Betriebsanweisung:
S22:Staub nicht einatmen.
S24/25:Berührung mit den Augen und der Haut vermeiden.
Beschreibung
This opium alkaloid occurs in the liquor following precipitation of Thebaine
(q.v.) and is purified by extraction with small quantities of Et20, followed by
precipitation with potassium iodide. The base crystallizes from hot C6H6 in
small, colourless needles and has [α]
15D+ 103.23° (EtOH). It is freely soluble in
CHCI3, EtOH, Et20 or hot C6H6 but insoluble in H20 or alkalies. No colour is
produced with FeCl 3 but with Fe203 and H2S04, a brown colour is formed,
changing to green when warmed to ISOoC. With concentrated H2S04 alone, the
alkaloid gives a rose-red colour, changing to deep violet at ISO°C. The solution
of the alkaloid in EtOH is alkaline to litmus and both it, and its salts, are bitter
to the taste. The crystalline methiodide has m.p. 218-221°C; [α]
D + 120°. The
oxidation products with Mn02 and H2S04 are veratraldehyde, 2:3:6:7-
tetramethoxy-9: I O-dihydroanthracene and laudaline (4: S-dimethoxy-2: -
methylaminoethylbenzaldehyde, m.p. 123-4°C. On exhaustive methylation it
yields trimethylamine and laudanosene (tetramethoxy-o-vinylstilbene). Laudanosine is one of the most convulsant of the opium alkaloids but possesses only a
slight analgesic action.
Chemische Eigenschaften
light yellow fine crystalline powder
l?uterung methode
Crystallise these from EtOH. The (±)-picrate crystallises from EtOH with m 177-178o. The (-)-isomer has m 83-85o and
Einzelnachweise
Pictet, Athanasescu., Ber., 33, 2347 (1900)
Pictet, Finkelstein., ibid, 42, 1979 (1909)
Pyman, Reynolds.,J. Chern. Soc., 97, 1324 (1910)
Kondo, Mori.,J. Ph arm. Soc., Japan, 51,615 (1931)
Craig, Tarbell., J. Amer. Chern. Soc., 70,2783 (1948)
Synthesis:
Pictet, Finkelstein., Compt. rend., 148,925 (1909)
Elliot.,J. Heterocycl. Chern., 7, 1229 (1970)
Pharmacology:
Zunz., Elements de Pharmacodynamie speciale, Tome I, 178, Masson & Co.,
Paris (1932)
Krueger, Eddy, Sumwalt., U.S. Public Health Reports, Suppl. 165, 1007
(1943)
(±)-1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisochinolin Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
